THE BUSINESS OF BIOTECH
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim
From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur Yochi Slonim made a name for himself in tech hubs around the globe. Notably, he was co-founder of billion-dollar Mercury Interactive, which HP acquired for $4.5 billion, and previous to that a leader at Tecnomatix, which sold to UGS and was acquired by Siemens. Those big deals that came on the heels of several other Yochi Slonim software startups. But Slonim's not in software development anymore.
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Yochi Slonim
Thomas Barnes
Rahul Kakkar
Bobby Reddy
Jason Gardner
Karen Harris
Michael Nally
Gavin Samuels
Robert Williamson
Brian Finrow
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air ? Contact us
RECENT EPISODES
FINANCE & CAPITAL MARKETS
IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel
Building A Biotech Hub With Intellia Therapeutics' John Leonard, M.D.
DISCOVERY
REGULATORY
MANUFACTURING
Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead
AAV & Lentiviral Gene Therapies With Sio Gene Therapies' Dr. Pavan Cheruvu
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
CDMO With A Pipeline Featuring Forge Biologics President & CEO Dr. Timothy J. Miller
Product Vs. Platform With Surface's Vito Palombella, Ph.D. And Robert Ross, M.D.